Advanced

Clinical proof of concept study (blossom) shows novel beta 3 adrenoceptor agonist YM178 is effective and well tolerated in the treatment of symptoms of overactive bladder

Chapple, C R; Yamaguchi, O; Ridder, A; Liehne, J; Carl, S; Mattiasson, Anders LU ; Arambunu, M A L; Lucas, M and Everaert, K (2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.239-239
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
European Urology Supplements
volume
7
issue
3
pages
239 - 239
publisher
Elsevier
conference name
23rd Annual Congress of the European Association of Urology, 2008
external identifiers
  • wos:000253839801076
ISSN
1569-9056
DOI
10.1016/S1569-9056(08)60672-7
language
English
LU publication?
yes
id
0bc43676-b9af-435e-a356-edb5844a1ee1 (old id 1186186)
date added to LUP
2008-09-03 13:35:16
date last changed
2017-02-22 11:44:15
@misc{0bc43676-b9af-435e-a356-edb5844a1ee1,
  author       = {Chapple, C R and Yamaguchi, O and Ridder, A and Liehne, J and Carl, S and Mattiasson, Anders and Arambunu, M A L and Lucas, M and Everaert, K},
  issn         = {1569-9056},
  language     = {eng},
  note         = {Conference Abstract},
  number       = {3},
  pages        = {239--239},
  publisher    = {Elsevier},
  series       = {European Urology Supplements},
  title        = {Clinical proof of concept study (blossom) shows novel beta 3 adrenoceptor agonist YM178 is effective and well tolerated in the treatment of symptoms of overactive bladder},
  url          = {http://dx.doi.org/10.1016/S1569-9056(08)60672-7},
  volume       = {7},
  year         = {2008},
}